{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:54:28Z","timestamp":1790420068797,"version":"4.1.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physical Medicine and Rehabilitation Clinics of North America"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.pmr.2013.06.002","type":"journal-article","created":{"date-parts":[[2013,7,25]],"date-time":"2013-07-25T04:07:01Z","timestamp":1374725221000},"page":"687-702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Visual Issues in Multiple Sclerosis"],"prefix":"10.1016","volume":"24","author":[{"given":"Courtney E.","family":"Francis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pmr.2013.06.002_bib1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ohc.2004.05.011","article-title":"Multiple sclerosis and the visual system","volume":"17","author":"Jacobs","year":"2004","journal-title":"Ophthalmol Clin North Am"},{"key":"10.1016\/j.pmr.2013.06.002_bib2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1474-4422(05)00992-0","article-title":"The neuro-ophthalmology of multiple sclerosis","volume":"4","author":"Frohman","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.pmr.2013.06.002_bib3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00055735-200212000-00006","article-title":"Acute demyelinating optic neuritis","volume":"13","author":"Foroozan","year":"2002","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.pmr.2013.06.002_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1474-4422(05)70071-5","article-title":"Clinically isolated syndromes suggestive of multiple sclerosis, part 1: natural history, pathogenesis, diagnosis, and prognosis","volume":"4","author":"Miller","year":"2005","journal-title":"Lancet Neurol"},{"issue":"Suppl 2","key":"10.1016\/j.pmr.2013.06.002_bib5","doi-asserted-by":"crossref","first-page":"s75","DOI":"10.1007\/s10072-005-0413-y","article-title":"Controversies in optic neuritis pain diagnosis","volume":"26","author":"Agostini","year":"2005","journal-title":"Neurol Sci"},{"key":"10.1016\/j.pmr.2013.06.002_bib6","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/archopht.1991.01080120057025","article-title":"The clinical profile of optic neuritis: experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group","volume":"109","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.pmr.2013.06.002_bib7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1001\/archopht.1993.01090020085029","article-title":"Baseline visual field profile of optic neuritis: the experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group","volume":"111","author":"Keltner","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.pmr.2013.06.002_bib8","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1001\/archopht.121.7.944","article-title":"High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the Optic Neuritis Treatment Trial","volume":"121","author":"Beck","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.pmr.2013.06.002_bib9","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1212\/WNL.49.5.1404","article-title":"The 5-year risk of MS after optic neuritis. Experience of the Optic Neuritis Treatment Trial. Optic Neuritis Treatment Group","volume":"49","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.pmr.2013.06.002_bib10","first-page":"73","article-title":"Inflammatory optic neuropathies","volume":"14","author":"Eggenberger","year":"2001","journal-title":"Ophthalmol Clin North Am"},{"key":"10.1016\/j.pmr.2013.06.002_bib11","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/S0161-6420(02)01148-X","article-title":"Use of magnetic resonance imaging to differentiate optic neuritis and nonarteritic anterior ischemic optic neuropathy","volume":"109","author":"Rizzo","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pmr.2013.06.002_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00234-004-1308-x","article-title":"The optic nerve sheath on MRI in acute optic neuritis","volume":"47","author":"Hickman","year":"2005","journal-title":"Neuroradiology"},{"issue":"Suppl 1","key":"10.1016\/j.pmr.2013.06.002_bib13","first-page":"S42","article-title":"Optic nerve imaging in multiple sclerosis","volume":"17","author":"Hickman","year":"2007","journal-title":"J\u00a0Neuroimaging"},{"key":"10.1016\/j.pmr.2013.06.002_bib14","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.20851","article-title":"Quantifying axonal loss after optic neuritis with optical coherence tomography","volume":"59","author":"Costello","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pmr.2013.06.002_bib15","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1177\/1352458508091367","article-title":"Tracking retinal nerve fiber layer loss after optic neuritis: a prospective study using optic coherence tomography","volume":"14","author":"Costello","year":"2008","journal-title":"Mult Scler"},{"key":"10.1016\/j.pmr.2013.06.002_bib16","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ana.20575","article-title":"Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis","volume":"58","author":"Trip","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pmr.2013.06.002_bib17","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1212\/01.wnl.0000295995.46586.ae","article-title":"Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis","volume":"69","author":"Gordon-Lipkin","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.pmr.2013.06.002_bib18","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1001\/jama.1995.03520320035038","article-title":"Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. The Ischemic Optic Neuropathy Decompression Trial Research Group","volume":"273","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.pmr.2013.06.002_bib19","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0140-6736(02)11919-2","article-title":"Management of acute optic neuritis","volume":"360","author":"Hickman","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.pmr.2013.06.002_bib20","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.pmr.2013.06.002_bib21","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/archopht.1988.01060140207023","article-title":"The Optic Neuritis Treatment Trial","volume":"106","author":"Beck","year":"1988","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.pmr.2013.06.002_bib22","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","article-title":"The Optic Neuritis Study Group. A randomized, controlled trial of corticosteroids in the treatment of optic neuritis","volume":"326","author":"Beck","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pmr.2013.06.002_bib23","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archopht.1993.01090060061023","article-title":"Optic Neuritis Treatment Trial. One-year follow-up results","volume":"111","author":"Beck","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.pmr.2013.06.002_bib24","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/archopht.1995.01100020014004","article-title":"The Optic Neuritis Treatment Trial: three-year follow-up results","volume":"113","author":"Beck","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.pmr.2013.06.002_bib25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0002-9394(03)00862-6","article-title":"Visual function more than 10 years after optic neuritis: experience of the Optic Neuritis Treatment Trial","volume":"137","author":"Beck","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.pmr.2013.06.002_bib26","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJM199312093292403","article-title":"The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis","volume":"329","author":"Beck","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pmr.2013.06.002_bib27","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.ophtha.2007.08.004","article-title":"Visual function 15 years after optic neuritis: A final follow-up report from the Optic Neuritis Treatment Trial","volume":"115","author":"Optic Neuritis Study Group","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pmr.2013.06.002_bib28","first-page":"727","article-title":"Multiple sclerosis risk after optic neuritis: Final Optic Neuritis Treatment Trial follow-up","volume":"65","author":"The Optic Neuritis Study Group","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pmr.2013.06.002_bib29","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM200009283431301","article-title":"Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis","volume":"343","author":"Jacobs","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pmr.2013.06.002_bib30","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0002-9394(01)01209-0","article-title":"Interferon \u00df-1a for optic neuritis patients at high risk for multiple sclerosis","volume":"132","author":"CHAMPS Study Group","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.pmr.2013.06.002_bib31","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0140-6736(00)04725-5","article-title":"Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study","volume":"357","author":"Comi","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.pmr.2013.06.002_bib32","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1212\/01.WNL.0000154521.40686.63","article-title":"Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis","volume":"64","author":"Baier","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.pmr.2013.06.002_bib33","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/archneur.65.7.924","article-title":"Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis","volume":"65","author":"Zaveri","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pmr.2013.06.002_bib34","first-page":"1555","article-title":"Optical coherence tomography in multiple sclerosis: thickness of the retinal nerve fiber layer as a potential measure of axonal loss and brain atrophy","volume":"255","author":"Siger","year":"2008","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.pmr.2013.06.002_bib35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jns.2007.10.020","article-title":"Retinal nerve fiber layer thickness is associated with brain MRI outcomes in multiple sclerosis","volume":"268","author":"Grazioli","year":"2008","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.pmr.2013.06.002_bib36","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.ophtha.2006.06.060","article-title":"Natural history of the visual impairment of relapsing neuromyelitis optica","volume":"114","author":"Merle","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pmr.2013.06.002_bib37","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devic\u2019s syndrome)","volume":"53","author":"Wingerchuk","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.pmr.2013.06.002_bib38","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/archneurol.2010.188","article-title":"Interferon beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers","volume":"67","author":"Palace","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pmr.2013.06.002_bib39","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/1352458506070732","article-title":"Immunosuppressive therapy is more effective than interferon in neuromyelitis optica","volume":"13","author":"Papeix","year":"2007","journal-title":"Mult Scler"},{"key":"10.1016\/j.pmr.2013.06.002_bib40","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1212\/WNL.0b013e3181f8832e","article-title":"IFN\u00df-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum","volume":"75","author":"Shimizu","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.pmr.2013.06.002_bib41","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1001\/archneurol.2011.216","article-title":"Failure of natalizumab to prevent relapses in neuromyelitis optica","volume":"69","author":"Kleiter","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pmr.2013.06.002_bib42","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/1352458511431973","article-title":"Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder","volume":"18","author":"Min","year":"2012","journal-title":"Mult Scler"},{"key":"10.1016\/j.pmr.2013.06.002_bib43","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1001\/archopht.1994.01090190094027","article-title":"Visual field profile of optic neuritis. One-year follow-up in the Optic Neuritis Treatment Trial","volume":"112","author":"Keltner","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.pmr.2013.06.002_bib44","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1212\/WNL.42.1.68","article-title":"Symptomatic retrochiasmal lesions in multiple sclerosis: clinical features, visual evoked potentials, and magnetic resonance imaging","volume":"42","author":"Plant","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.pmr.2013.06.002_bib45","first-page":"569","article-title":"Role of eye movement examination and subjective visual vertical in clinical evaluation of multiple sclerosis","volume":"250","author":"Serra","year":"2003","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.pmr.2013.06.002_bib46","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00041327-200503000-00018","article-title":"See-saw nystagmus as the presenting sign in multiple sclerosis","volume":"25","author":"Sandramouli","year":"2005","journal-title":"J\u00a0Neuroophthalmol"},{"key":"10.1016\/j.pmr.2013.06.002_bib47","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1212\/WNL.56.2.276","article-title":"Periodic alternating nystagmus in a patient with MS","volume":"56","author":"Matsumoto","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.pmr.2013.06.002_bib48","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/archneur.1974.00490350057009","article-title":"Periodic alternating nystagmus with downward beating nystagmus. A clinicoanatomical case study of multiple sclerosis","volume":"30","author":"Keane","year":"1974","journal-title":"Arch Neurol"},{"issue":"Pt 4","key":"10.1016\/j.pmr.2013.06.002_bib49","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/brain\/117.4.789","article-title":"Jerk-waveform see-saw nystagmus due to unilateral meso-diencephalic lesion","volume":"117","author":"Halmagyi","year":"1994","journal-title":"Brain"},{"key":"10.1016\/j.pmr.2013.06.002_bib50","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1212\/WNL.50.2.551","article-title":"Primary position upbeat nystagmus increased on downward gaze: clinicopathologic study of a patient with multiple sclerosis","volume":"50","author":"Ohkoshi","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.pmr.2013.06.002_bib51","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1749-6632.2002.tb02849.x","article-title":"Saccadic and vestibular abnormalities in multiple sclerosis: sensitive clinical signs of brainstem and cerebellar involvement","volume":"956","author":"Downey","year":"2002","journal-title":"Ann N Y Acad Sci"},{"issue":"Pt 2","key":"10.1016\/j.pmr.2013.06.002_bib52","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/brain\/118.2.369","article-title":"Investigations of the pathogen- esis of acquired pendular nystagmus","volume":"118","author":"Averbuch-Heller","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.pmr.2013.06.002_bib53","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/jnnp.56.3.262","article-title":"Acquired pendular nystagmus in multiple sclerosis: clinical observations and the role of optic neuropathy","volume":"56","author":"Barton","year":"1993","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pmr.2013.06.002_bib54","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/ana.410410620","article-title":"A\u00a0double-blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus","volume":"41","author":"Averbuch-Heller","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pmr.2013.06.002_bib55","first-page":"9","article-title":"Drug therapy for acquired pendular nystagmus in multiple sclerosis","volume":"244","author":"Starck","year":"1997","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.pmr.2013.06.002_bib56","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11940-005-0008-0","article-title":"Current treatment of nystagmus","volume":"7","author":"Rucker","year":"2005","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.pmr.2013.06.002_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jnnp.74.1.1","article-title":"Drug treatments for eye movement disorders","volume":"74","author":"Leigh","year":"2003","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pmr.2013.06.002_bib58","first-page":"665","article-title":"Ocular motor disorders associated with cerebellar lesions: pathophysiology and topical localization","volume":"149","author":"Lewis","year":"1993","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.pmr.2013.06.002_bib59","first-page":"455","article-title":"Internuclear ophthalmoplegia: pathophysiology and diagnosis","volume":"1","author":"Zee","year":"1992","journal-title":"Baillieres Clin Neurol"},{"key":"10.1016\/j.pmr.2013.06.002_bib60","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/archneur.62.5.714","article-title":"Internuclear ophthalmoplegia: unusual causes in 114 of 410 patients","volume":"62","author":"Keane","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pmr.2013.06.002_bib61","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-0404.2004.00278.x","article-title":"Internuclear ophthalmoplegia: causes and long-term follow-up in 65 patients","volume":"110","author":"Bolanos","year":"2004","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.pmr.2013.06.002_bib62","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1212\/01.WNL.0000085863.54218.72","article-title":"Accuracy of clinical detection of INO in MS: corroboration with quantitative infrared oculography","volume":"61","author":"Frohman","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.pmr.2013.06.002_bib63","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1212\/01.wnl.0000324423.08538.dd","article-title":"Break in fusion during head turning in MS patients with INO","volume":"71","author":"Mills","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.pmr.2013.06.002_bib64","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1212\/WNL.33.8.971","article-title":"The one-and-a-half syndrome \u2013 a unilateral disorder of the pontine tegmentum: a study of 20 cases and review of the literature","volume":"33","author":"Wall","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.pmr.2013.06.002_bib65","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/jnnp.63.5.682","article-title":"Isolated cranial nerve palsies in multiple sclerosis","volume":"63","author":"Thomke","year":"1997","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pmr.2013.06.002_bib66","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.clineuro.2008.02.009","article-title":"Isolated cranial nerve palsies in multiple sclerosis","volume":"110","author":"Zadro","year":"2008","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.pmr.2013.06.002_bib67","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1212\/WNL.58.10.1532","article-title":"Painful third nerve palsy in MS","volume":"58","author":"Bentley","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.pmr.2013.06.002_bib68","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1212\/WNL.53.4.877","article-title":"Isolated trochlear nerve palsy in patients with multiple sclerosis","volume":"53","author":"Jacobson","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.pmr.2013.06.002_bib69","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1001\/archopht.1984.01040031078029","article-title":"Isolated sixth-nerve palsies in younger adults","volume":"102","author":"Moster","year":"1984","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.pmr.2013.06.002_bib70","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.survophthal.2005.12.008","article-title":"Skew deviation revisited","volume":"51","author":"Brodsky","year":"2006","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.pmr.2013.06.002_bib71","first-page":"145","article-title":"Paralysie des mouvements associ\u00e9s des yeux","volume":"5","author":"Parinaud","year":"1883","journal-title":"Archives de neurologie, Paris"},{"key":"10.1016\/j.pmr.2013.06.002_bib72","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1191\/1352458504ms1043oa","article-title":"An unsual variant of the dorsal midbrain syndrome in MS: clinical characteristics and pathophysiologic mechanisms","volume":"10","author":"Frohman","year":"2004","journal-title":"Mult Scler"},{"key":"10.1016\/j.pmr.2013.06.002_bib73","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1212\/01.WNL.0000036304.22698.24","article-title":"Parinaud syndrome heralding MS","volume":"60","author":"Lee","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.pmr.2013.06.002_bib74","first-page":"249","article-title":"Surgical treatment of upgaze palsy in Parinaud\u2019s syndrome","volume":"8","author":"Buckley","year":"2004","journal-title":"J\u00a0AAPOS"},{"key":"10.1016\/j.pmr.2013.06.002_bib75","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1136\/bjo.2003.040519","article-title":"Neurological concomitants of uveitis","volume":"88","author":"Smith","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.pmr.2013.06.002_bib76","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1212\/WNL.52.1.179","article-title":"Multiple sclerosis associated with uveitis in two large clinic-based series","volume":"52","author":"Biousse","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.pmr.2013.06.002_bib77","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/01.icu.0000179804.49842.e2","article-title":"Ocular manifestations of multiple sclerosis","volume":"16","author":"Chen","year":"2005","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.pmr.2013.06.002_bib78","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/09273940490895344","article-title":"Mulitple sclerosis-associated uveitis","volume":"12","author":"Zein","year":"2004","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.pmr.2013.06.002_bib79","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1442-9071.2000.00270.x","article-title":"Symptomatic intraocular inflammation in multiple sclerosis","volume":"28","author":"Towler","year":"2000","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.pmr.2013.06.002_bib80","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0161-6420(99)90122-7","article-title":"Pars planitis: clinical features and class II HLA associations","volume":"106","author":"Raja","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pmr.2013.06.002_bib81","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1076\/ocii.9.2.93.3975","article-title":"Pars planitis: epidemiology, treatment and association with multiple sclerosis","volume":"9","author":"Prieto","year":"2001","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.pmr.2013.06.002_bib82","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1126\/science.1070238","article-title":"Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists","volume":"296","author":"Mandala","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.pmr.2013.06.002_bib83","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJMoa0909494","article-title":"A\u00a0placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis","volume":"362","author":"Kappos","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pmr.2013.06.002_bib84","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1056\/NEJMoa0907839","article-title":"Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis","volume":"362","author":"Cohen","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pmr.2013.06.002_bib85","series-title":"Highlights of prescribing information: Gilenya (fingolimod) capsules","year":"2012"},{"key":"10.1016\/j.pmr.2013.06.002_bib86","unstructured":"Lee AG, Ophthalmic News & Education (ONE) Network Neuro-Ophthalmology Committee, Oral MS drug may increase risk for macular edema: a report from the North American Neuro-Ophthalmology Society (NANOS) and the AAO, ONE Network Neuro-Ophthalmology Committee; 2011."},{"key":"10.1016\/j.pmr.2013.06.002_bib87","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S1474-4422(10)70028-4","article-title":"Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases","volume":"9","author":"Clifford","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.pmr.2013.06.002_bib88","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0733-8619(18)31105-8","article-title":"Progressive multifocal leukoencephalopathy","volume":"2","author":"Brooks","year":"1984","journal-title":"Neurol Clin"}],"container-title":["Physical Medicine and Rehabilitation Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047965113000296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047965113000296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T03:37:05Z","timestamp":1760931425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047965113000296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":88,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S1047965113000296"],"URL":"https:\/\/doi.org\/10.1016\/j.pmr.2013.06.002","relation":{},"ISSN":["1047-9651"],"issn-type":[{"value":"1047-9651","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Visual Issues in Multiple Sclerosis","name":"articletitle","label":"Article Title"},{"value":"Physical Medicine and Rehabilitation Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pmr.2013.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}